We are excited to introduce our new Director Dr. Béranger Lueza who joined our international Modelling, Access and Strategy unit this week. Béranger is based in Stockholm and has more than 11 years of experience in Health Economics and Outcomes Research and Market Access from consultancy and academia. “We are very pleased and extremely happy that Béranger decided to join our team and believe that he will make the Modelling, Access and Strategy unit even stronger! I am sure his experience and in-depth knowledge of health-economic modeling and HTA requirements, combined with his statistical background, will be highly appreciated by clients, partners and colleagues.“ Rosa Lauppe, head of the unit, points out.

Prior to joining Quantify, Béranger lead HEOR projects, French HTA submissions, individual patient data analysis and more in his role as Regional Manager Europe and as part of the Senior leadership teams at Amaris and Icon. He also spent seven years as a Health Economist and Biostatistician at Gustave Roussy Cancer Campus in Paris. During his career Béranger has been lead author or co-author of 15+ peer-reviewed manuscripts in top-tier clinical and methodological journals, and 20+ oral presentations or posters at conferences.

We are so happy to have you on the team, Béranger!